Immunomax

Immunomax: immune stimulant for the treatment of infections and pathological conditions

Immunomax is a drug intended to stimulate the immune system and treat infections and pathological conditions caused by various viruses and bacteria. There are several varieties of the drug produced in Russia and Finland.

The manufacturers of the drug Immunomax in Russia are the company Immapharma, and in Finland – Hankintatukku Oy. The drug is available in the form of a lyophilized powder for the preparation of an injection solution of 200 units.

The composition of the drug Immunomax includes acidic peptidoglycan with a molecular weight of 1000-40,000 kDa. This component is an effective immune stimulant and helps improve the body's protective functions.

Indications for use of the drug Immunomax include correction of weakened immunity, treatment of pathological conditions (condylomas, warts, dysplasia) caused by the human papillomavirus, as well as infections caused by Herpes simplex, Chlamydia spp., Mycoplasma spp., Ureaplasma spp. viruses. and other bacteria and viruses.

Contraindications to the use of Immunomax include children under 12 years of age, hypersensitivity to the drug, as well as pregnancy and breastfeeding.

When using the drug Immunomax according to indications and in recommended doses, no side effects were detected. Drug interactions with Immunomax have not been described. To date, no cases of overdose of Immunomax have been reported.

It is possible to use the drug Immunomax as part of complex therapy according to indications.

Thus, the drug Immunomax is an effective remedy for stimulating the immune system and treating infections and pathological conditions caused by various viruses and bacteria. However, before using the drug, you should consult your doctor and read the instructions for use.